Deoxyadenosine (dAdo) and deoxyguanosine (dGuo) decrease methionine synthesis from homocysteine in cultured lymphoblasts; because of the possible trapping of 5-methyltetrahydrofolate this could lead to decreased purine nucleotide synthesis. Since purine deoxynucleosides could also inhibit purine synthesis de novo at an early step not involving folate metabolism, we measured in azaserine-treated cells 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis using ['4C]formate. In the T lymphoblasts, Z-base-dependent purine nucleotide synthesis was decreased 26O% by 0.3 /zM-dAdo, 210% by 1 ,tM-dGuo and 28% by 1 /uM-adenosine dialdehyde, a potent S-adenosylhomocysteine hydrolase inhibitor; homocysteine fully reversed the inhibitions. The B lymphoblasts were considerably less sensitive to the deoxynucleoside-induced decrease in Z-base-dependent purine nucleotide synthesis, with 100/ttM-dAdo required for significant inhibition and no inhibition by dGuo at this concentration; homocysteine partly reversed the inhibition by dAdo. The observed decrease in Z-base-dependent purine nucleotide synthesis could not be attributed either to dUMP depletion changing the folate pools or to decreased ATP availability because dUrd was without effect and during the experimental period the intracellular ATP concentration did not change significantly. Cells with 5, 10-methylenetetrahydrofolate reductase deficiency were relatively resistant to inhibition of Z-base-dependent purine nucleotide synthesis by dAdo and adenosine dialdehyde. Our results suggest that deoxynucleosides decrease purine nucleotide synthesis by trapping 5-methyltetrahydrofolate.
INTRODUCTION
Adenosine deaminase (EC 3.5.4.4) deficiency leads to severe combined immunodeficiency disease, a disorder of T and B cell function with T cell function more severely affected than B cell function [1, 2] , while purine nucleoside phosphorylase (EC 2.4.4.1) deficiency leads to isolated T cell dysfunction [3, 4] . The toxic metabolites in these two disorders appear to be dAdo and dGuo, respectively [5, 6] .
There are two major mechanisms of dAdo toxicity. The first is through ribonucleotide diphosphate reductase inhibition because of dATP accumulation [7] and the second is through direct AdoHcy hydrolase (EC 3.3.1.1) inhibition [8, 9] . Less is known about the mechanism of dGuo toxicity, but the associated dGTP accumulation may inhibit ribonucleotide diphosphate reductase [10, 11] .
We showed recently that purine deoxynucleosides decrease methionine synthesis from homocysteine in cultured human T lymphoblasts and, less severely, in B lymphoblasts [12] . This defect could be reversed by the addition of homocysteine, suggesting that the purine deoxynucleosides caused trapping of 5-methyltetrahydrofolate. The homocysteine-utilizing enzyme methionine synthetase is the only reaction that converts 5-methyltetrahydrofolate to free tetrahydrofolate, and thus to other folates, because 5-methyltetrahydrofolate production from 5,10-methylenetetrahydrofolate is essentially irreversible in vivo ( Fig. 1 ) [13] .
We hypothesized, therefore, that purine deoxynucleosides and the potent and specific AdoHcy hydrolase inhibitor adenosine dialdehyde would induce 5-methyltetrahydrofolate trapping by decreasing homocysteine availability; this would in turn decrease purine synthesis de novo which is folate-dependent. To exclude feedback inhibition by deoxynucleoside derivatives of early steps of the de novo pathway, we measured in azaserine-treated cells Z-base-dependent purine nucleotide synthesis using [14C]formate. ZMP is a late intermediate of the de novo pathway requiring only a formyl group from 10-formyltetrahydrofolate to complete the purine ring ( Fig.  1) . We found that dAdo and adenosine dialdehyde decreased Z-base-dependent purine nucleotide synthesis in the T and B lymphoblasts whereas dGuo decreased purine synthesis only in the T lymphoblasts. Adenosine and guanosine were poor inhibitors of Z-base-dependent purine nucleotide synthesis. Abbreviations used: dAdo, 2'-deoxyadenosine; dGuo, 2'-deoxyguanosine; AdoHcy, S-adenosylhomocysteine; AdoMet, S-adenosylmethionine; Z-base, 5-amino-4-imidazolecarboxamide; Z-riboside, 5-amino-4-imidazolecarboxamide riboside; ZMP, 5-amino-4-imidazolecarboxamide ribotide; dUrd, 2'-deoxyuridine. [12, 14] . The adenosine deaminase-deficient and purine nucleoside phosphorylase-deficient cells had < 1 % of residual enzyme activities as compared with cells derived from healthy controls, whereas the methylene tetrahydrofolate reductase-deficient cells had approx. 18% of the normal enzyme activity [12, 14] . Cells were routinely cultured in RPMI-1640 medium (Irvine Scientific, Irvine, CA, U.S.A.) supplemented with 10% (v/v) fetal bovine serum as previously described [14] . Preparation of experimental culture medium The experimental culture medium was prepared as previously described and was serum-free, containing 5 g of extensively dialysed fatty acid-free bovine serum albumin/litre (Sigma A7030) [15] . Unless otherwise noted, the medium was folate-deficient and contained 1.5 /sM-cobalamin, 100 units of penicillin/ml, 100 ,g of streptomycin/ml and methionine at the physiological concentration of 30 4UM. Similar results were obtained when methionine was present at 10 or 100,M. Measurement of rates of Z-base-dependent purine nucleotide synthesis Deoxyribonucleotides, resulting from phosphorylation of the deoxynucleosides, can decrease purine synthesis de novo by inhibiting phosphoribosylpyrophosphate synthetase [16] . In addition, the deoxyribonucleotides can be metabolized via a series of degradative and salvage reactions to yield ribonucleotides which additionally inhibit amidophosphoribosyltransferase, the first committed reaction of the de novo pathway [17] . To exclude these mechanisms of purine synthesis inhibition and focus specifically on deoxynucleoside-induced alterations in folate-purine metabolism, we measured Z-basedependent purine nucleotide synthesis in azaserinetreated cells. Azaserine at 50/SM completely blocks purine synthesis de novo by inhibiting the fourth step of the pathway [18] . We showed in preliminary experiments that the toxic effect of 50 ,sM-azaserine on cell growth was 1987 426 It I a) I I reversed fully by 200 1sM-Z-base. This indicates that: (i) the only major effect ofazaserine at this concentration is inhibition of purine synthesis de novo and (ii) Z-base is an appropriate compound to reverse this toxicity. Similar results were obtained when Z-riboside was used.
METHODS
Cells were recovered by centrifugation from the growth medium and resuspended at a density of 1.0 x 106/ml in the experimental medium containing 50 ,uM-azaserine and 200 /SM-Z-base. The cell suspension was transferred to 16 mm x 100 mm glass tubes which were flushed with air/CO2 (19:1), capped and placed in a 37°C shaking water bath. Cell viability, as measured by Trypan Blue exclusion, exceeded 900 after 18 h under these conditions. In the homocysteine reversal experiments, 300 /tM-DL-homocysteine thiolactone was added; similar results were obtained when DL-homocysteine was prepared fresh by base hydrolysis [12] . Neither cysteine nor homocystine could be substituted for homocysteine.
In the experiments with dAdo and adenosine, 5 ,tM-2'-deoxycoformycin, a potent inhibitor of adenosine deaminase (supplied by the Drug Development Agency, National Institutes of Health, Bethesda, MD, U.S.A.) was added 1 h prior to the addition of the dAdo or adenosine. Similarly, in the experiments with dGuo and guanosine, 50 ,uM-8-aminoguanosine, an inhibitor of purine nucleoside phosphorylase (provided by Dr. Shih-Hsi Chu, Brown University, Providence, RI, U.S.A.) was added 1 h prior to the addition of the dGuo or guanosine. Neither 2'-deoxycoformycin nor 8-aminoguanosine inhibit AdoHcy hydrolase [19] and at the concentrations used they did not inhibit Z-basedependent purine nucleotide synthesis. These inhibitors were not used with 889, the adenosine deaminasedeficient cell line, 679, the purine nucleoside phosphorylase-deficient cell line, or in the experiments with adenosine dialdehyde {2'-O-[(R)-formyl(adenine-9-yl)-methyl]-(R)-glyceraldehyde; periodate-oxidized adenosine; adenosine 2',3'-dialdehyde; Sigma A7154} since the latter compound is not a substrate for adenosine deaminase [20] .
The (deoxy)nucleoside to be tested was added for 12 h; qualitatively similar results, but with less inhibition, were added to 1 ml of cell suspension; 90 min later the tubes were cooled on ice and cells and media were extracted separately in 0.4 M-HCl04 [18] . The ribose-purine and Pi-ribose bonds were hydrolysed by heating the tubes at 100°C for 70 min; the tubes were cooled and centrifuged and the supernatants were applied to 0.7 cm x 2 cm Dowex-50 cation-exchange columns. The columns were washed twice with 10 ml of 0.1 M-HCl and the purines were eluted in 5 ml of 6 M-HCl of which 1 [21] . The assay was linear with time to at least 2 h and with cell number from 0.5 x 106 to 2 x 106 cells/ml. Measurement of intracellular purine nucleotides Approx. 6 x 106 cells were incubated for 12 h under the conditions described for the measurement of Z-basedependent purine nucleotide synthesis. They were extracted and analysed by h.p.l.c. as previously described [18] .
RESULTS

Purine synthesis in T lymphoblasts
At 0.3 #uM, dAdo reduced rates of Z-base-dependent purine nucleotide synthesis by 26% in the T lymphoblasts Vol. 242 Table 1 . Inhibition of Z-base-dependent purine nucleotide synthesis by adenosine dialdehyde in the T lymphoblast line CCRF-CEM, the B lymphoblast line MGL8B2 and the 5,10-methylenetetrahydrofolate reductase-deficient B lymphoblast line MGL28
Rates of Z-base-dependent purine nucleotide synthesis were measured as described in the legend to Fig. 2 (Fig. 2a) . However, at dAdo concentrations of 1 ,UM or greater, where further inhibition of Z-base-dependent purine nucleotide synthesis occurred, homocysteine had no appreciable effect.
At 0.1, 0.3 or 1 ,UM, dGuo decreased rates of Z-base-dependent purine nucleotide synthesis by approx.
210% in the T lymphoblasts (P < 0.05, t test) with again full reversal to control values by homocysteine (Fig. 2b) . At higher dGuo concentrations homocysteine produced only minimal recovery.
Unlike the deoxynucleosides, the two nucleosides adenosine and guanosine at concentrations as high as at 10 /tM in the T lymphoblast line CCRF-CEM (Table   1) . Homocysteine fully reversed this decrease in Z-basedependent purine nucleotide synthesis. This suggests that the decrease in purine nucleotide synthesis was secondary to 5-methyltetrahydrofolate accumulation because of decreased intracellular homocysteine production by AdoHcy hydrolase inhibition (Fig. 1) .
Purine synthesis in B lymphoblasts
In the B lymphoblasts, dAdo was a considerably less potent inhibitor of Z-base-dependent purine nucleotide synthesis than in the T lymphoblasts (compare Figs. 3 and 2a, noting the difference in the abscissa scale), significantly inhibiting Z-base-dependent purine nucleotide synthesis only at 100 /IM. Homocysteine increased Z-base-dependent purine nucleotide synthesis by approx. 20% in the control untreated state, suggesting that the intracellular homocysteine concentration may normally be limiting for 5-methyltetrahydrofolate conversion to tetrahydrofolate. Only partial recovery of Z-basedependent purine nucleotide synthesis was observed on the addition of homocysteine at 100 ,#M-dAdo (Fig. 3) .
Unlike in the T lymphoblasts, dGuo at concentrations as high as 100 /M did not inhibit Z-base-dependent purine nucleotide synthesis in the B lymphoblasts. The nucleosides adenosine and guanosine again were poor inhibitors of Z-base-dependent purine nucleotide synthesis in the B lymphoblasts with significant inhibition occurring only at 30 and 100 /sM, respectively. Homocysteine did not overcome the inhibition induced by these relatively high nucleoside concentrations.
In the B lymphoblast line MG18B2, adenosine dialdehyde reduced rates of Z-base-dependent purine nucleotide synthesis by 250% at 1 /M and by 510% at 10 1uM (Table 1 ). The inhibition of purine nucleotide synthesis observed at 1 /tM-adenosine dialdehyde was reversed fully by homocysteine while that observed at 10 /tM-adenosine dialdehyde was reversed by more than 750.
Purine synthesis in adenosine deaminase-or purine nucleoside phosphorylase-deficient B lymphoblasts
In the adenosine deaminase-deficient cell line, a B cell line, dAdo inhibited Z-base-dependent purine nucleotide To elucidate further the mechanism of the decrease in Z-base-dependent purine nucleotide synthesis, 5,10-methylenetetrahydrofolate reductase-deficient B lymphoblasts were studied. Because 5-methyltetrahydrofolate synthesis from 5, 10-methylenetetrahydrofolate is impaired in these cells (Fig. 1) , their intracellular 5-methyltetrahydrofolate concentration and methionine synthesis from homocysteine are decreased [14, 23] . They would be expected, therefore: (i) to be less sensitive to 5-methyltetrahydrofolate trapping from AdoHcy hydrolase inhibition and (ii) to show little response to homocysteine rescue of AdoHcy hydrolase inhibition. Rates of Z-base-dependent purine nucleotide synthesis were not affected by I ,tM-adenosine dialdehyde and were decreased only 26% by 10 /M of this compound; addition of homocysteine was without benefit (Table 1) . Similar resistance to dAdo-induced decrease in Z-basedependent purine nucleotide synthesis was found in these cells. Purine synthesis in folic acid-treated cells One might expect that folic acid (pteroylglutamic acid) could replenish the free tetrahydrofolate pool in cells in which 5-methyltetrahydrofolate conversion to tetrahydrofolate is decreased (Fig. 1) . However, in concentrations as high as 1 mm, folic acid did not reverse the deoxynucleoside-induced decrease in rates of Z-basedependent purine nucleotide synthesis in either the T or B lymphoblasts. 5-Formyltetrahydrofolate (Leucovorin) could not be used in these studies because it excessively diluted the radioactive 10-formyltetrahydrofolate pool.
Purine synthesis in dUrd-treated cells dAdo and dGuo could decrease the intracellular dUMP concentration because of ribonucleotide diphosphate reductase inhibition by dATP and dGTP. The consequent decreased conversion of dUMP to dTMP could lead to an increase in the 5,10-methylenetetrahydrofolate concentration with increased conversion to either 5-methyltetrahydrofolate and/or 10-formyltetrahydrofolate (Fig. 1) . The increased 5-methyltetrahydrofolate synthesis would be another mechanism of 5-methyltetrahydrofolate trapping in the deoxynucleoside-treated cells, while increased 10-formyltetrahydrofolate synthesis would decrease the specific radioactivity of the added [14C]formate. Rates of Z-base-dependent purine nucleotide synthesis in the control state as well as in the dAdo or dGuo-treated cells were, however, unaffected by 1, 3 or 10 ,M-dUrd. Intracellular purine nucleotides The Km of rabbit liver 10-formyltetrahydrofolate synthetase ( Fig. 1) for ATP is 67 /tM [24] . Therefore, a significant decrease in the intracellular ATP concentration, which in cultured lymphoblasts is about 2 mm [15] , could interfere with ourmeasurementofZ-base-dependent purine nucleotide synthesis. In the T lymphoblasts, the intracellular concentration of ATP, ADP, GTP or GDP was not changed significantly by a 12 h incubation with 1 /M of either dAdo or dGuo (Table 2) , a concentration which significantly decreased Z-base-dependent purine nucleotide synthesis in the cells (Fig. 2) . However, longer incubation times at these deoxynucleoside concentrations did decrease the intracellular concentration of the nucleotides. The marked decrease in the intracellular concentration of the nucleotides induced by 10 #M-dAdo (Table 2 ) may contribute to the striking reduction of Z-base-dependent purine nucleotide synthesis observed at this dAdo concentration where homocysteine had no significant effect (Fig. 2a) . In the B lymphoblasts, dAdo at concentrations as high as 100 /M had no significant effect on the intracellular concentration of purine nucleotides (Table 2) . Adenosine dialdehyde at 1 ,UM neither changed the intracellular concentration of purine nucleotides nor was converted to a nucleotide form in either the T or B lymphoblasts.
DISCUSSION
We showed previously that methionine synthesis is inhibited by submicromolar concentrations of dAdo and Vol. 242 dGuo in cultured T and B lymphoblasts; dAdo was a more potent inhibitor than dGuo and T lymphoblasts were considerably more sensitive to this inhibition than B lymphoblasts [12] . We now show that Z-base-dependent purine nucleotide synthesis is inhibited by similarly low dAdo and dGuo concentrations in T lymphoblasts and only by relatively high dAdo concentrations in B lymphoblasts.
The experiments with the potent and specific AdoHcy hydrolase inhibitor adenosine dialdehyde demonstrate that decreased intracellular homocysteine production leads to decreased Z-base-dependent purine nucleotide synthesis. This decrease seems to be secondary to 5-methyltetrahydrofolate trapping because it could be reversed fully by homocysteine and 5, 10-methylenetetrahydrofolate reductase-deficient cells exhibited drug resistance.
Although dAdo is a suicide inhibitor of AdoHcy hydrolase [8] , this does not appear to be its major mechanism ofinhibiting Z-base-dependent purine nucleotide synthesis. The total AdoHcy hydrolase activity of T and B lymphoblasts is similar and the enzyme from these two sources is equally sensitive to dAdo inhibition [25] ; dAdo should, therefore, have inhibited Z-base-dependent purine nucleotide synthesis similarly in these two cell types as occurred with adenosine dialdehyde. In addition, dGuo does not inhibit AdoHcy hydrolase but it was as potent an inhibitor of Z-base-dependent purine nucleotide synthesis in the T lymphoblasts as was dAdo. Two lines of evidence suggest, however, that the mechanism of the decrease in Z-base-dependent purine nucleotide synthesis was through 5-methyltetrahydrofolate trapping. First, at the low deoxynucleoside concentrations where the nucleotide pools were not changed significantly, homocysteine fully reversed the decrease in Z-basedependent purine nucleotide synthesis. It is unlikely that homocysteine reversed the inhibition through some other mechanism, such as providing reducing thiol groups, because 100 ,tM-cystine was present in the experimental medium and neither homocysteine nor cysteine effected reversal. Secondly, the 5, 10-methylenetetrahydrofolate reductase-deficient B lymphoblasts were relatively resistant to dAdo.
The major difference found to date between T and B lymphoblasts in response to deoxynucleosides is the higher accumulation of deoxynucleotides in the T lymphoblasts [7] . The greater inhibition of Z-basedependent purine nucleotide synthesis in the T lymphoblasts noted in our study suggests an, as yet unknown, effect of deoxynucleotides on folate metabolism. This effect does not appear to be through dUMP depletion because dUrd was without effect. Most previous studies would not have noted the deoxynucleoside-induced inhibition of purine synthesis that we have found, because they have been performed in serum-containing medium (fetal bovine, horse or human). At a final concentration of 10% these sera will add 0.5-5 /tM of purines to the medium, a concentration sufficient to provide purine nucleotides required by the cell via the salvage pathway [26, 27] . It is notable that hypoxanthine attenuates dGuo toxicity in at least two cell systems [28, 29] .
The finding that the intracellular concentration of purine nucleotides did not decrease significantly during the experimental period at deoxynucleoside concentrations which decreased Z-base-dependent purine nucleotide-synthesis relates, in part, to the relatively large size of the nucleotide pools compared with the hourly rate of purine nucleotide synthesis. Thus, the hourly rate of purine nucleotide synthesis in CCRF-CEM is approx. 8o% of the total nucleotide pool (Tables 1 and 2 ). Since 1 ,m-dAdo decreased this rate by 310% (Fig. 2a) , the maximal decrease in the nucleotide pool at this dAdo concentration could be approx. 2.4% /h. However, deoxynucleosides are known to decrease DNA and RNA synthesis [29, 30] and this decrease in the' demand for purine nucleotides may explain why we measured only a 500 decrease in the concentration of purine nucleotides after a 12 h incubation with 1 ,/M-dAdo (Table 2 ).
It is curious that folic acid (pteroylglutamic acid) did not reverse the deoxynucleoside-induced decrease in Z-base-dependent purine nucleotide synthesis. Similar results were obtained recently when methionine synthetase activity was inhibited by N2O-induced inactivation of cobalamin [31] . There may be several reasons for this.
First, pteroylglutamic acid is not the preferred substrate for the folate transporter, but rather 5-methyltetrahydrofolate [13] . Second, dihydrofolate reductase activity may be limiting since the preferred substrate of this enzyme is dihydrofolate, not folic acid [13] . And third, most folate cofactors are considerably more active as polyglutamates and addition of the extra glutamate residues may be slow [32] .
These data provide a biochemical basis for the megaloblastic anaemia regularly associated with purine nucleoside phosphorylase deficiency and occasionally associated with adenosine deaminase deficiency [2] [3] [4] . Furthermore, 2'-deoxycoformycin treatment of patients with acute lymphocytic leukaemia raises the plasma dAdo concentration and induces megaloblastic anaemia (personal communication from Dr. A. L. Yu, University of California, San Diego). Leucovorin might prove beneficial in these conditions.
